584 related articles for article (PubMed ID: 22674144)
1. The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.
McAllister CS; Kagnoff MF
Semin Immunopathol; 2012 Jul; 34(4):581-600. PubMed ID: 22674144
[TBL] [Abstract][Full Text] [Related]
2. Treatment of celiac disease: from gluten-free diet to novel therapies.
Francavilla R; Cristofori F; Stella M; Borrelli G; Naspi G; Castellaneta S
Minerva Pediatr; 2014 Oct; 66(5):501-16. PubMed ID: 24938882
[TBL] [Abstract][Full Text] [Related]
3. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
4. Celiac disease: risk assessment, diagnosis, and monitoring.
Setty M; Hormaza L; Guandalini S
Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
[TBL] [Abstract][Full Text] [Related]
5. Novel therapeutic approaches for celiac disease.
Vanga RR; Kelly CP
Discov Med; 2014 May; 17(95):285-93. PubMed ID: 24882720
[TBL] [Abstract][Full Text] [Related]
6. Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy.
Noori E; Hashemi N; Rezaee D; Maleki R; Shams F; Kazemi B; Bandepour M; Rahimi F
Int Immunopharmacol; 2024 May; 133():112020. PubMed ID: 38608449
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic options for coeliac disease: What else beyond gluten-free diet?
Caio G; Ciccocioppo R; Zoli G; De Giorgio R; Volta U
Dig Liver Dis; 2020 Feb; 52(2):130-137. PubMed ID: 31831308
[TBL] [Abstract][Full Text] [Related]
8. Reinventing the nutraceutical value of gluten: The case of l-theanine-gluten as a potential alternative to the gluten exclusion diet in celiac disease.
Ribeiro M; Lopes S; Picascia S; Gianfrani C; Nunes FM
Food Chem; 2020 Sep; 324():126840. PubMed ID: 32344339
[TBL] [Abstract][Full Text] [Related]
9. Gluten Degrading Enzymes for Treatment of Celiac Disease.
Wei G; Helmerhorst EJ; Darwish G; Blumenkranz G; Schuppan D
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32679754
[TBL] [Abstract][Full Text] [Related]
10. Celiac disease: prevention and treatment.
Selimoğlu MA; Karabiber H
J Clin Gastroenterol; 2010 Jan; 44(1):4-8. PubMed ID: 20027009
[TBL] [Abstract][Full Text] [Related]
11. Future therapeutic options for celiac disease.
Sollid LM; Khosla C
Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):140-7. PubMed ID: 16265155
[TBL] [Abstract][Full Text] [Related]
12. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
[TBL] [Abstract][Full Text] [Related]
13. Gluten immunogenic peptide excretion detects dietary transgressions in treated celiac disease patients.
Costa AF; Sugai E; Temprano MP; Niveloni SI; Vázquez H; Moreno ML; Domínguez-Flores MR; Muñoz-Suano A; Smecuol E; Stefanolo JP; González AF; Cebolla-Ramirez A; Mauriño E; Verdú EF; Bai JC
World J Gastroenterol; 2019 Mar; 25(11):1409-1420. PubMed ID: 30918433
[TBL] [Abstract][Full Text] [Related]
14. Indications and Use of the Gluten Contamination Elimination Diet for Patients with Non-Responsive Celiac Disease.
Leonard MM; Cureton P; Fasano A
Nutrients; 2017 Oct; 9(10):. PubMed ID: 29057833
[TBL] [Abstract][Full Text] [Related]
15. Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease.
Cellier C; Cervoni JP; Patey N; Leborgne M; Marteau P; Landi B; Cerf-Bensussan N; Barbier JP; Brousse N
Am J Gastroenterol; 1998 Sep; 93(9):1527-30. PubMed ID: 9732937
[TBL] [Abstract][Full Text] [Related]
16. Physiopathology and Management of Gluten-Induced Celiac Disease.
Kumar J; Kumar M; Pandey R; Chauhan NS
J Food Sci; 2017 Feb; 82(2):270-277. PubMed ID: 28140462
[TBL] [Abstract][Full Text] [Related]
17. In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.
Lindfors K; Rauhavirta T; Stenman S; Mäki M; Kaukinen K
Exp Biol Med (Maywood); 2012 Feb; 237(2):119-25. PubMed ID: 22282398
[TBL] [Abstract][Full Text] [Related]
18. In Situ Gluten-Chitosan Interlocked Self-Assembled Supramolecular Architecture Reduces T-Cell-Mediated Immune Response to Gluten in Celiac Disease.
Ribeiro M; Picascia S; Rhazi L; Gianfrani C; Carrillo JM; Rodriguez-Quijano M; Branlard G; Nunes FM
Mol Nutr Food Res; 2018 Dec; 62(23):e1800646. PubMed ID: 30289620
[TBL] [Abstract][Full Text] [Related]
19. New therapeutic strategies for celiac disease.
Lerner A
Autoimmun Rev; 2010 Jan; 9(3):144-7. PubMed ID: 19427921
[TBL] [Abstract][Full Text] [Related]
20. Are xenogeneic anti-tissue transglutaminase antibodies the holy grail for celiac patients?
Ivanovski PI; Ivanovski IP; Sedlarevic R
Med Hypotheses; 2007; 69(6):1257-60. PubMed ID: 17553630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
